[1] ARCA E， TASTAN H B， AKAR A， et al. An open， randomized， comparative study of oral fluconazole， itraconazole and terbinafine therapy in onychomycosis[J] .J Dermatolog Treat， 2002， 13(1)：3-9. [2] SALO H， PEKURINEN M. Cost effectiveness of oral terbinafine (Lamisil) compared with oral fluconazole (Diflucan) in the treatment of patients with toenail onychomycosis[J] . Pharmacoeconomics， 2002， 20(5)：319-324. [3] GUPTA A K， GREGUREK-NOVAK T. Efficacy of itraconazole， terbinafine， fluconazole， griseofulvin and ketoconazole in the treatment of scopulariopsis brevicaulis causing onychomycosis of the toes[J] . Dermatology， 2001， 202(3)：235-238. [4] SIGURGEIRSSON B， BILLSTEIN S， RANTANEN T， et al. L.I.ON. Study： efficacy and tolerability of continuous terbinafine (Lamisil)compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. Itraconazole in onychomycosis[J] . Br J Dermatol，1999， 141(S56)：5-14. [5] VAN DER SCHROEFF J G， CIRKEL P K， CRIJNS M B， et al. A randomized treatment duration-finding study of terbinafine in onychomycosis[J] . Br J Dermatol， 1992， 126 (S39)：36-39. [6] SIGURGEIRSSON B， OLAFSSON J H， STEINSSON J B，et al. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis： a 5-year blinded prospective follow-up study[J] . Arch Dermatol， 2002， 138(3)：353-357. [7] GUPTA A K， LYNDE C W， KONNIKOV N. Single-blind， randomized， prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis[J] .J Am Acad Dermatol，2001， 44(3)：485-491. [8] GUPTA A K， KONNIKOV N， LYNDE C W. Single-blind， randomized， prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly[J] .J Am Acad Dermatol，2001， 44(3)：479-484. [9] HAVU V， HEIKKILA H， KUOKKANEN K， et al. A double-blind， randomized study to compare the efficacy and safety of terbinafine (Lamisil) with fluconazole (Diflucan) in the treatment of onychomycosis[J] .Br J Dermatol， 2000， 142(1)：97-102. [10] KEJDA J. Itraconazole pulse therapy vs continuous terbinafine dosing for toenail onychomycosis[J] . Postgrad Med， 1999，9：12-15. [11] DEGREEF H， DEL PALACIO A， MYGIND S， et al. Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis[J] .Acta Derm Venereol， 1999， 79(3)：221-223. [12] EVANS E G， SIGURGEIRSSON B. Double blind， randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis[J] .BMJ， 1999， 318(7190)：1031-1035. [13] DRAKE L A， SHEAR N H， ARLETTE J P，et al. Oral terbinafine in the treatment of toenail onychomycosis： North American multicenter trial[J] .J Am Acad Dermatol，1997， 37(5 Pt 1)：740-745. [14] TAUSCH I， BRAUTIGAM M， WEIDINGER G， et al. Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy[J] . Br J Dermatol， 1997， 136(5)：737-742. [15] ELLIS D H， WATSON A B， MARLEY J E， et al. Non-dermatophytes in onychomycosis of the toenails[J] . Br J Dermatol，1997，136(4)：490-493. [16] ALPSOY E， YILMAZ E， BBASARAN E. Intermittent therapy with terbinafine for dermatophyte toe-onychomycosis： a new approach[J] . J Dermatol，1996 ，23(4)：259-262. [17] TOSTI A， PIRACCINI B M， STINCHI C， et al. Treatment of dermatophyte nail infections： an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy[J] .J Am Acad Dermatol，1996，34(4)：595-600. [18] DE BACKER M， DE KEYSER P， DE VROEY C， et al. A 12-week treatment for dermatophyte toe onychomycosis： terbinafine 250 mg/day vs. itraconazole 200 mg/day-a double-blind comparative trial[J] . Br J Dermatol，1996， 134 (S46)：16-17. [19] WATSON A， MARLEY J， ELLIS D， et al. Terbinafine in onychomycosis of the toenail： a novel treatment protocol[J] .J Am Acad Dermatol，1995，33(5 Pt 1)：775-779. [20] BRAUTIGAM M， NOLTING S， SCHOPF R E， et al. Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection.Seventh lamisil german onychomycosis study group[J] .BMJ， 1995，311(7010)：919-922. [21] FAERGEMANN J， ANDERSON C， HERSLE K， et al. Double-blind， parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis[J] .J Am Acad Dermatol，1995，32(5 Pt 1)：750-753. [22] ARENAS R， DOMINGUEZ-CHERIT J， FERNANDEZ L M. Open randomized comparison of itraconazole versus terbinafine in onychomycosis[J] .Int J Dermatol，1995，34(2)：138-143. [23] GOODFIELD M J， ANDREW L， EVANS E G. Short term treatment of dermatophyte onychomycosis with terbinafine[J] .BMJ，1992， 304(6835)：1151-1154. [24] SAVIN R C. Oral terbinafine versus griseofulvin in the treatment of moccasin-type tinea pedis[J] .J Am Acad Dermatol，1990，23(4 Pt 2)：807-809. [25] LECHA M. Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain[J] .Br J Dermatol，2001，145(S60)：21-26. [26] ELEWSKI B E， SCHER R K， ALY R， et al. Double-blind， randomized comparison of itraconazole capsules vs. placebo in the treatment of toenail onychomycosis[J] .Cutis，1997，59(4)：217-220. [27] HANEKE E， DELESCLUSE J， PLINCK E， et al. The use of itraconazole in onychomycosis[J] .Eur J Dermatol， 1996，6(1)：7-12. [28] HANEKE E， TAJERBASHI M， de DONCKER P， et al. Itraconazole in the treatment of onychomycosis： a double-blind comparison with miconazole[J] .Dermatology，1998，196(3)：323-329. [29] HAVU V， BRANDT H， HEIKKILA H， et al. A double-blind， randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis[J] .Br J Dermatol， 1997， 136(2)：230-234. [30] HONEYMAN J F， TALARICO F S， ARRUDA L H F， et al. Itraconazole versus terbinafine(Lamisil)：which is better for the treatment of onychomycosis[J] .J Eur Acad Dermatol，1997， 9(2)：215-221. [31] JONES H E， ZAIAS N. Double-blind， randomized comparison of itraconazole capsules and placebo in the treatment of onychomycosis of the toenail[J] .Int J Dermatol，1996， 35(8)：589-590. [32] ODOM R， DANIEL C R， ALY R. A double-blind， randomized comparison of itraconazole capsules and placebo in the treatment of onychomycosis of the toenail[J] .J Am Acad Dermatol， 1996， 35(1)：110-111. [33] Itraconazole product monopraph[Z] . Titusville(NJ)：Janssen Pharmaceutica Inc.，1996. [34] WANG A P， LI R Y， WANG D L， et al. A double blind randomized controlled clinical trail of the treatment in superficial mycoses with terbinafine[J] .Chin J Clin Pharmacol，1997， 13(2)：71-77. [35] GU J L， LIAO W Q， QIN W Z， et al．Multicentre randomized comparative clinical study of topical 1% terbinafine cream vs 1% lamisil cream in the treatment of superficial mycoses[J] .Chin J Dermatovenereol，1999，13(5)：274-276. [36] FU Q， ZHU Z， LIU H J， et al. Study on bioequivalence of domestic itraconazole capsules[J] .Chin Pharm J， 2001， 36(5)：323-325. [37] LIU W， LI R Y， CHEN Q， et al. Levels of terbinafine in nail samples during and after terbinafine of fingernail onychomycosis with terbinafine for 4 weeks [J] .Chin J Clin Pharmacol，1999， 15(6)：435-439.